Abstract
3-(1H-Imidazol-4-yl)propylguanidine (SK&F 91486, 4) was identified as a potent partial agonist at the human histamine H(3) receptor (hH(3)R) and human histamine H(4) receptor (hH(4)R). With the aim to increase selectivity for the hH(4)R, the guanidine group in 4 was acylated. N(1)-Acetyl-N(2)-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-PI288, 13) was a potent full agonist at the hH(4)R (pEC(50) = 8.31; alpha = 1.00), possessing more than 1000- and 100-fold selectivity relative to the hH(1)R and hH(2)R, respectively, and possessing only low intrinsic activity (alpha = 0.27) at the hH(3)R.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Line
-
Guanidines / chemical synthesis*
-
Guanidines / chemistry
-
Guanidines / pharmacology
-
Humans
-
Imidazoles / chemical synthesis*
-
Imidazoles / chemistry
-
Imidazoles / pharmacology
-
Insecta
-
Receptors, G-Protein-Coupled / agonists*
-
Receptors, G-Protein-Coupled / antagonists & inhibitors
-
Receptors, G-Protein-Coupled / genetics
-
Receptors, Histamine / genetics
-
Receptors, Histamine H4
-
Recombinant Fusion Proteins / agonists
-
Recombinant Fusion Proteins / antagonists & inhibitors
-
Recombinant Fusion Proteins / genetics
-
Structure-Activity Relationship
Substances
-
Guanidines
-
HRH4 protein, human
-
Imidazoles
-
N1-acetyl-N2-(3-(1H-imidazol-4-yl)propyl)guanidine
-
Receptors, G-Protein-Coupled
-
Receptors, Histamine
-
Receptors, Histamine H4
-
Recombinant Fusion Proteins